Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Status:
Recruiting
Trial end date:
2024-11-25
Target enrollment:
Participant gender:
Summary
This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs.
enzalutamide after confirmation of the starting dose of talazoparib in combination with
enzalutamide.